Artelo Biosciences, Inc. (ARTL)
5.85
-0.13
(-2.17%)
USD |
NASDAQ |
Sep 10, 14:17
Artelo Biosciences Shareholders Equity (Quarterly) : 4.997M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.997M |
| March 31, 2026 | 6.672M |
| December 31, 2025 | -1.272M |
| September 30, 2025 | -0.633M |
| June 30, 2025 | -1.406M |
| March 31, 2025 | 0.652M |
| December 31, 2024 | 2.857M |
| September 30, 2024 | 6.361M |
| June 30, 2024 | 7.299M |
| March 31, 2024 | 9.537M |
| December 31, 2023 | 11.75M |
| September 30, 2023 | 14.58M |
| June 30, 2023 | 16.27M |
| March 31, 2023 | 17.64M |
| December 31, 2022 | 19.40M |
| September 30, 2022 | 21.90M |
| June 30, 2022 | 23.84M |
| March 31, 2022 | 25.78M |
| August 31, 2021 | 12.04M |
| Date | Value |
|---|---|
| May 31, 2021 | 11.92M |
| February 28, 2021 | 12.86M |
| November 30, 2020 | 9.054M |
| August 31, 2020 | 3.875M |
| May 31, 2020 | 3.225M |
| February 29, 2020 | 3.708M |
| November 30, 2019 | 4.963M |
| August 31, 2019 | 5.461M |
| May 31, 2019 | 0.1344M |
| February 28, 2019 | -0.6922M |
| November 30, 2018 | -0.4752M |
| August 31, 2018 | -0.135M |
| May 31, 2018 | -0.0913M |
| February 28, 2018 | 0.3853M |
| November 30, 2017 | 0.294M |
| August 31, 2017 | 0.5448M |
| May 31, 2017 | -0.1139M |
| February 28, 2017 | -0.0195M |
| November 30, 2016 | -0.0065M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 705.78M |
| Veru, Inc. | 28.38M |
| Johnson & Johnson | 84.97B |
| Eli Lilly & Co. | 33.88B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 6.459M |
| Total Liabilities (Quarterly) | 1.462M |
| Debt to Equity Ratio | 0.0098 |
| Current Ratio | 3.004 |
| Net Debt Paydown Yield | 0.02% |